Authors:
Shida, K
Shiratori, I
Matsumoto, M
Fukumori, Y
Matsuhisa, A
Kikkawa, S
Tsuji, S
Okamura, H
Toyoshima, K
Seya, T
Citation: K. Shida et al., An alternative form of IL-18 in human blood plasma: Complex formation withIgM defined by monoclonal antibodies, J IMMUNOL, 166(11), 2001, pp. 6671-6679
Authors:
Tsuji, S
Uehori, J
Matsumoto, M
Suzuki, Y
Matsuhisa, A
Toyoshima, K
Seya, T
Citation: S. Tsuji et al., Human intelectin is a novel soluble lectin that recognizes galactofuranosein carbohydrate chains of bacterial cell wall, J BIOL CHEM, 276(26), 2001, pp. 23456-23463
Authors:
Matsumoto, Y
Tsuzuki, R
Matsuhisa, A
Yoden, T
Yamagiwa, Y
Yanagisawa, I
Shibanuma, T
Nohira, H
Citation: Y. Matsumoto et al., Novel potassium channel openers. Part 4: Transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine, BIO MED CH, 8(2), 2000, pp. 393-404
Authors:
Miyamoto, R
Sugiura, R
Kamitani, S
Yada, T
Lu, YB
Sio, SO
Asakura, M
Matsuhisa, A
Shuntoh, H
Kuno, T
Citation: R. Miyamoto et al., Tol1, a fission yeast phosphomonoesterase, is an in vivo target of lithium, and its deletion leads to sulfite auxotrophy, J BACT, 182(13), 2000, pp. 3619-3625
Authors:
Shimada, Y
Taniguchi, N
Matsuhisa, A
Sakamoto, K
Yatsu, T
Tanaka, A
Citation: Y. Shimada et al., Highly potent and orally active non-peptide arginine vasopressin antagonists for both V-1A and V-2 receptors: Synthesis and pharmacological properties of 4 '-[(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-yl)carbonyl]-2-phenylbenzanilide derivatives, CHEM PHARM, 48(11), 2000, pp. 1644-1651
Authors:
Matsuhisa, A
Taniguchi, N
Koshio, H
Yatsu, T
Tanaka, A
Citation: A. Matsuhisa et al., Nonpeptide arginine vasopressin antagonists for both V-1A and V-2 receptors: Synthesis and pharmacological properties of 4 '-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanilide derivatives and 4 '-(5,6-Dihydro-4H-thiazolo[5,4-d][1]benzoazepine-6-carbonyl)benzanilide derivatives, CHEM PHARM, 48(1), 2000, pp. 21-31
Authors:
Matsumoto, Y
Tsuzuki, R
Matsuhisa, A
Masuda, N
Yamagiwa, Y
Yanagisawa, I
Shibanuma, T
Nohira, H
Citation: Y. Matsumoto et al., Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: Modification of the aromatic part, CHEM PHARM, 47(7), 1999, pp. 971-979
Authors:
Matsuhisa, A
Kikuchi, K
Sakamoto, K
Yatsu, T
Tanaka, A
Citation: A. Matsuhisa et al., Nonpeptide arginine vasopressin antagonists for both V-1A and V-2 receptors: Synthesis and pharmacological properties of 4 '-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl]benzanilide and 4 '-[5-(substituted methyl)-2,3-dihydro-1H-1-benzoazepine-1-carbonyl]benzanilide derivatives, CHEM PHARM, 47(3), 1999, pp. 329-339